Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hajizadeh, Nima
31  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

PRISMA 2020 flow diagram for new systematic reviews which i..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.g001.  , 2024
Link: https://doi.org/10.1371/..
 
?
2

Characteristics of eligible studies utilizing tumor necrosi..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.t002.  , 2024
Link: https://doi.org/10.1371/..
 
?
3

The list of search strategies and final results on each dat..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s003.  , 2024
Link: https://doi.org/10.1371/..
 
?
4

The list of search strategies and final results on each dat..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s003.  , 2024
Link: https://doi.org/10.1371/..
 
?
5

The quality assessment included case reports and case serie..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s006.  , 2024
Link: https://doi.org/10.1371/..
 
?
6

PRISMA 2020 checklist for reporting systematic reviews:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s001.  , 2024
Link: https://doi.org/10.1371/..
 
?
7

Characteristics of eligible studies with tumor necrosis fac..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.t003.  , 2024
Link: https://doi.org/10.1371/..
 
?
8

Characteristics of eligible studies utilizing tumor necrosi..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.t002.  , 2024
Link: https://doi.org/10.1371/..
 
?
9

The quality assessment included observational cohort and cr..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s004.  , 2024
Link: https://doi.org/10.1371/..
 
?
10

PRISMA 2020 checklist for reporting systematic reviews:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s001.  , 2024
Link: https://doi.org/10.1371/..
 
?
11

The quality assessment included before-after studies with n..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s005.  , 2024
Link: https://doi.org/10.1371/..
 
?
12

The quality assessment included case reports and case serie..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s006.  , 2024
Link: https://doi.org/10.1371/..
 
?
13

The quality assessment included observational cohort and cr..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s004.  , 2024
Link: https://doi.org/10.1371/..
 
?
14

Characteristics of eligible studies utilizing Janus kinase ..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.t001.  , 2024
Link: https://doi.org/10.1371/..
 
?
15

PRISMA 2020 checklist for abstracts of systematic reviews:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s002.  , 2024
Link: https://doi.org/10.1371/..
 
1-15